REMSIMA 10 MG/ML PO LIOF CT FA VD INC X 10 ML
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1921600010010 -
GGREM
545116050000007 -
Código de barras
7898576550028
O que a fonte publica
- Detentor do registro
- CELLTRION HEALTHCARE DISTRIBUICAO DE PRODUTOS FARMACEUTICOS DOS BRASIL LTDA
- Princípios ativos
- INFLIXIMABE
- Embalagem
- 10 MG/ML PO LIOF CT FA VD INC X 10 ML
- Tipo de produto
- Biológico
- Classe terapêutica
- L4B - PRODUTOS ANTI-TNF( FATOR DE NECROSE TUMORAL)
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "REMSIMA 10 MG/ML PO LIOF CT FA VD INC X 10 ML",
"holder": "CELLTRION HEALTHCARE DISTRIBUICAO DE PRODUTOS FARMACEUTICOS DOS BRASIL LTDA",
"stripe": null,
"barcodes": [
"7898576550028"
],
"confaz87": true,
"currency": "BRL",
"marketed": null,
"ggremCode": "545116050000007",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "05.452.889/0001-61",
"priceRegime": "Regulado",
"productName": "REMSIMA",
"productType": "Biológico",
"hospitalOnly": false,
"presentation": "10 MG/ML PO LIOF CT FA VD INC X 10 ML",
"sourceStatus": null,
"supplyRegime": null,
"factoryPrices": {
"icms-0": "2764.17",
"icms-12": "3141.10",
"icms-17": "3330.32",
"icms-18": "3370.94",
"icms-19": "3412.56",
"icms-20": "3455.21",
"icms-21": "3498.95",
"icms-22": "3543.81",
"icms-23": "3589.83",
"icms-17.5": "3350.51",
"icms-19.5": "3433.75",
"icms-20.5": "3476.94",
"icms-22.5": "3566.67",
"icms-12-alc": "3103.41",
"icms-17-alc": "3290.36",
"icms-18-alc": "3330.49",
"icms-19-alc": "3371.60",
"icms-20-alc": "3413.75",
"icms-21-alc": "3456.96",
"icms-22-alc": "3501.28",
"icms-23-alc": "3546.75",
"withoutTaxes": "2731.00",
"icms-17.5-alc": "3310.30",
"icms-19.5-alc": "3392.55",
"icms-20.5-alc": "3435.22",
"icms-22.5-alc": "3523.87"
},
"pisCofinsList": "Positiva",
"substanceText": "INFLIXIMABE",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "3810.12",
"icms-12": "4329.68",
"icms-17": "4590.50",
"icms-18": "4646.49",
"icms-19": "4703.86",
"icms-20": "4762.65",
"icms-21": "4822.94",
"icms-22": "4884.77",
"icms-23": "4948.21",
"icms-17.5": "4618.33",
"icms-19.5": "4733.07",
"icms-20.5": "4792.60",
"icms-22.5": "4916.28",
"icms-12-alc": "4290.28",
"icms-17-alc": "4548.73",
"icms-18-alc": "4604.21",
"icms-19-alc": "4661.04",
"icms-20-alc": "4719.31",
"icms-21-alc": "4779.04",
"icms-22-alc": "4840.31",
"icms-23-alc": "4903.17",
"withoutTaxes": "3775.45",
"icms-17.5-alc": "4576.30",
"icms-19.5-alc": "4690.00",
"icms-20.5-alc": "4748.99",
"icms-22.5-alc": "4871.54"
},
"invalidBarcodes": [],
"activeSubstances": [
"INFLIXIMABE"
],
"therapeuticClass": "L4B - PRODUTOS ANTI-TNF( FATOR DE NECROSE TUMORAL)",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": "(11)",
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1921600010010",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "unknown",
"prescriptionRequired": null,
"therapeuticClassCode": "L4B",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:545116050000007"